Works matching IS 10109609 AND DT 2012 AND VI 26 AND IP 3
Results: 41
Pharmacovigilance Risk Assessment Committee.
- Published in:
- 2012
- Publication type:
- Journal Article
Pyrantel oral suspension.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 297
- Publication type:
- Article
Abacavir oral solution Abacaviri solutionum peroralum.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 293
- Publication type:
- Article
Revision of monograph on capsules.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 289
- Publication type:
- Article
The International Pharmacopoeia.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 284
- Publication type:
- Article
Assessing risk of resistance in antimalarial compounds.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 283
- Publication type:
- Article
Procurement of reproductive health supplies.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 283
- Publication type:
- Article
HIV treatment in twenty-three countries.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 282
- Publication type:
- Article
Patent searches on essential medicines.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 282
- Publication type:
- Article
Pharmacovigilance: towards a safer use of medicines.
- Published in:
- 2012
- Publication type:
- Book Review
Paediatric morphine dosage.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 278
- Publication type:
- Article
Lenalidomide: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 277
- Publication type:
- Article
Tesamorelin: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 276
- Publication type:
- Article
Semuloparin sodium: withdrawal of marketing authorization application.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 276
- Publication type:
- Article
Trimetazidine-containing medicines: restricted use.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 276
- Publication type:
- Article
Tolperisone: restricted use.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 275
- Publication type:
- Article
Teduglutide approved for short bowel syndrome.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 275
- Publication type:
- Article
Alipogene tiparvovec approved for lipoprotein lipase deficiency.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 275
- Publication type:
- Article
Lorcaserin approved for overweight or obese adults.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 274
- Publication type:
- Article
Mirabegron approved for overactive bladder.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 274
- Publication type:
- Article
Emtricitabine/tenofovir disoproxil fumarate approved for HIV.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 273
- Publication type:
- Article
Online publication of suspected side-effect reports.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 273
- Publication type:
- Article
Dabigatran: positive benefit-risk balance.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 272
- Publication type:
- Article
Doripenem: dosing review for nosocomial pneumonia.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 272
- Publication type:
- Article
Calcitonin medicines: limit long-term use.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 271
- Publication type:
- Article
Denosumab: severe hypocalcaemia.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 271
- Publication type:
- Article
Human immune globulin: haemolytic reactions.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 270
- Publication type:
- Article
Hepatitis B immune globulin: thrombotic events.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 270
- Publication type:
- Article
Ambrisentan: idiopathic pulmonary fibrosis.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 270
- Publication type:
- Article
Serotonergic medicines: cerebral vasoconstriction syndrome.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 269
- Publication type:
- Article
Somatropin: Increased risk of mortality?
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 268
- Publication type:
- Article
Statins and ciclosporin: risk of myopathy.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 267
- Publication type:
- Article
Boceprevir: drug interaction.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 267
- Publication type:
- Article
Aprotinin: restricted access programme.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 267
- Publication type:
- Article
Strontium ranelate: serious skin reactions.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 266
- Publication type:
- Article
Vessel sealing system: torn vessels.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 266
- Publication type:
- Article
Cefepime: risk of seizure.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 265
- Publication type:
- Article
Extended-release and long-acting opioid medications.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 265
- Publication type:
- Article
Ondansetron: QT prolongation.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 265
- Publication type:
- Article
WHO Prequalification of Medicines Programme.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 248
- By:
- Publication type:
- Article
Regulator prequalification of medicines: a future concept for networking.
- Published in:
- WHO Drug Information, 2012, v. 26, n. 3, p. 239
- Publication type:
- Article